The role of ferroptosis in cancer development and treatment response

Frontiers in Pharmacology

Volumn 8, Issue JAN, 2018, Pages

  Lu, Bin ^a   Chen, Xiao Bing ^a   Ying, Mei Dan ^a   He, Qiao Jun ^a   Cao, Ji ^a   Yang, Bo ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cancer therapeutics; Ferroptosis; Iron metabolism; Lipid ROS; Tumorigenesis

Indexed keywords

ANTINEOPLASTIC AGENT; ARTESUNATE; CISPLATIN; ERASTIN; HEAT SHOCK PROTEIN 27; HEME OXYGENASE 1; LAPATINIB; SIRAMESINE; SORAFENIB; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ACUTE MYELOID LEUKEMIA; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; DIFFUSE LARGE B CELL LYMPHOMA; DMT1 GENE; FERROPTOSIS; FPN GENE; FTH1 GENE; FTL GENE; GLIOBLASTOMA; HEAD AND NECK CANCER; HUMAN; IRON METABOLISM; LIPID PEROXIDATION; LIVER CELL CARCINOMA; MALIGNANT NEOPLASM; NON SMALL CELL LUNG CANCER; NONHUMAN; ONCOGENE; OSTEOSARCOMA; OVARY CANCER; PANCREAS ADENOCARCINOMA; PROSTATE ADENOCARCINOMA; RENAL CELL CARCINOMA; REVIEW; TF GENE; TFR1 GENE; TREATMENT RESPONSE; TRIPLE NEGATIVE BREAST CANCER; UTERINE CERVIX CARCINOMA;

EID: 85040462389     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00992     Document Type: Review

References (57)

1. Amaravadi, R. K., and Thompson, C. B. (2007). The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 13, 7271-7279. doi: 10.1158/1078-0432.CCR-07-1595
2. Bogdan, A. R., Miyazawa, M., Hashimoto, K., and Tsuji, Y. (2016). Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem. Sci. 41, 274-286. doi: 10.1016/j.tibs.2015.11.012
3. Bridges, R. J., Natale, N. R., and Patel, S. A. (2012). System xc(-) cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br. J. Pharmacol. 165, 20-34. doi: 10.1111/j.1476-5381.2011.01480.x
4. Chen, H., Zheng, C., Zhang, Y., Chang, Y. Z., Qian, Z. M., and Shen, X. (2006). Heat shock protein 27 downregulates the transferrin receptor 1-mediated iron uptake. Int. J. Biochem. Cell Biol. 38, 1402-1416. doi: 10.1016/j.biocel.2006.02.006
5. Chen, L., Li, X., Liu, L., Yu, B., Xue, Y., and Liu, Y. (2015). Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-gamma-lyase function. Oncol. Rep. 33, 1465-1474. doi: 10.3892/or.2015.3712
6. Conrad, M., Angeli, J. P., Vandenabeele, P., and Stockwell, B. R. (2016). Regulated necrosis: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 15, 348-366. doi: 10.1038/nrd.2015.6
7. Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., et al. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072. doi: 10.1016/j.cell.2012.03.042
8. Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., et al. (2014). Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife 3:e02523. doi: 10.7554/eLife.02523
9. Dixon, S. J., Winter, G. E., Musavi, L. S., Lee, E. D., Snijder, B., Rebsamen, M., et al. (2015). Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem. Biol. 10, 1604-1609. doi: 10.1021/acschembio.5b00245
10. Dolma, S., Lessnick, S. L., Hahn, W. C., and Stockwell, B. R. (2003). Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3, 285-296. doi: 10.1016/S1535-6108(03)00050-3
11. Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A., and Brady, N. R. (2015). Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2, 517-532. doi: 10.18632/oncoscience.160
12. Fatokun, A. A., Dawson, V. L., and Dawson, T. M. (2014). Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br. J. Pharmacol. 171, 2000-2016
13. Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., et al. (2014). Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180-1191. doi: 10.1038/ncb3064
14. Galmiche, A., Chauffert, B., and Barbare, J. C. (2014). New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma. Cancer Lett. 346, 159-162. doi: 10.1016/j.canlet.2013.12.028
15. Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., and Jiang, X. (2016). Ferroptosis is an autophagic cell death process. Cell Res. 26, 1021-1032. doi: 10.1038/cr.2016.95
16. Gao, M., Monian, P., Quadri, N., Ramasamy, R., and Jiang, X. (2015). Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell 59, 298-308. doi: 10.1016/j.molcel.2015.06.011
17. Greenshields, A. L., Shepherd, T. G., and Hoskin, D. W. (2016). Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate. Mol. Carcinog. 56, 75-93. doi: 10.1002/mc.22474
18. Hasegawa, M., Takahashi, H., Rajabi, H., Alam, M., Suzuki, Y., Yin, L., et al. (2016). Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget 7, 11756-11769. doi: 10.18632/oncotarget.7598
19. Hayano, M., Yang, W. S., Corn, C. K., Pagano, N. C., and Stockwell, B. R. (2016). Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ. 23, 270-278. doi: 10.1038/cdd.2015.93
20. Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M. T., Zeh, H. J., et al. (2016). Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12, 1425-1428. doi: 10.1080/15548627.2016.1187366
21. Houessinon, A., Francois, C., Sauzay, C., Louandre, C., Mongelard, G., Godin, C., et al. (2016). Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib. Mol. Cancer 15:38. doi: 10.1186/s12943-016-0526-2
22. Huang, Y., Dai, Z., Barbacioru, C., and Sadee, W. (2005). Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 65, 7446-7454. doi: 10.1158/0008-5472.CAN-04-4267
23. Jiang, L., Kon, N., Li, T., Wang, S. J., Su, T., Hibshoosh, H., et al. (2015). Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57-62. doi: 10.1038/nature14344
24. Kerr, J. F., Winterford, C. M., and Harmon, B. V. (1994). Apoptosis. Its significance in cancer and cancer therapy. Cancer 73, 2013-2026. doi: 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J
25. Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S. (2005). The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 5, 726-734. doi: 10.1038/nrc1692
26. Kroll, M. H., Jiji, V., and Jiji, R. (1984). Microcytic hypochromic anemia associated with renal cell carcinoma. South Med. J. 77, 635-637. doi: 10.1097/00007611-198405000-00024
27. Kwon, M. Y., Park, E., Lee, S. J., and Chung, S. W. (2015). Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget 6, 24393-24403. doi: 10.18632/oncotarget.5162
28. Levine, B. (2006). Unraveling the role of autophagy in cancer. Autophagy 2, 65-66. doi: 10.4161/auto.2.2.2457
29. Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., et al. (2012). Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149, 1269-1283. doi: 10.1016/j.cell.2012.04.026
30. Li, T., Liu, X., Jiang, L., Manfredi, J., Zha, S., and Gu, W. (2016). Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging. Oncotarget 7, 11838-11849. doi: 10.18632/oncotarget.7864
31. Lin, R., Zhang, Z., Chen, L., Zhou, Y., Zou, P., Feng, C., et al. (2016). Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. Cancer Lett. 381, 165-175. doi: 10.1016/j.canlet.2016.07.033
32. Liu, L., Yang, M., Kang, R., Wang, Z., Zhao, Y., Yu, Y., et al. (2011). HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 25, 23-31. doi: 10.1038/leu.2010.225
33. Liu, X. X., Li, X. J., Zhang, B., Liang, Y. J., Zhou, C. X., Cao, D. X., et al. (2011). MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett. 585, 1363-1367. doi: 10.1016/j.febslet.2011.04.018
34. Liu, Y., Wang, W., Li, Y., Xiao, Y., Cheng, J., and Jia, J. (2015). The 5-lipoxygenase inhibitor zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis. Biol. Pharm. Bull. 38, 1234-1239. doi: 10.1248/bpb.b15-00048
35. Louandre, C., Marcq, I., Bouhlal, H., Lachaier, E., Godin, C., Saidak, Z., et al. (2015). The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells. Cancer Lett. 356, 971-977. doi: 10.1016/j.canlet.2014.11.014
36. Ma, S., Henson, E. S., Chen, Y., and Gibson, S. B. (2016). Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 7:e2307. doi: 10.1038/cddis.2016.208
37. Ooko, E., Saeed, M. E., Kadioglu, O., Sarvi, S., Colak, M., Elmasaoudi, K., et al. (2015). Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine 22, 1045-1054. doi: 10.1016/j.phymed.2015.08.002
38. Pommier, Y., Sordet, O., Antony, S., Hayward, R. L., and Kohn, K. W. (2004). Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23, 2934-2949. doi: 10.1038/sj.onc.1207515
39. Roh, J. L., Kim, E. H., Jang, H. J., Park, J. Y., and Shin, D. (2016). Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Cancer Lett. 381, 96-103. doi: 10.1016/j.canlet.2016.07.035
40. Rossi, A., Pergola, C., Koeberle, A., Hoffmann, M., Dehm, F., Bramanti, P., et al. (2010). The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br. J. Pharmacol. 161, 555-570. doi: 10.1111/j.1476-5381.2010.00930.x
41. Sato, H., Shiiya, A., Kimata, M., Maebara, K., Tamba, M., Sakakura, Y., et al. (2005). Redox imbalance in cystine/glutamate transporter-deficient mice. J. Biol. Chem. 280, 37423-37429. doi: 10.1074/jbc.M506439200
42. Sehm, T., Rauh, M., Wiendieck, K., Buchfelder, M., Eyupoglu, I. Y., and Savaskan, N. E. (2016). Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis. Oncotarget 7, 74630-74647. doi: 10.18632/oncotarget.11858
43. Shimada, K., Skouta, R., Kaplan, A., Yang, W. S., Hayano, M., Dixon, S. J., et al. (2016). Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat. Chem. Biol. 12, 497-503. doi: 10.1038/nchembio.2079
44. Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., et al. (2014). Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 136, 4551-4556. doi: 10.1021/ja411006a
45. Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., et al. (2013). Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 4:e838. doi: 10.1038/cddis.2013.350
46. Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., et al. (2016). Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63, 173-184. doi: 10.1002/hep.28251
47. Sun, X., Ou, Z., Xie, M., Kang, R., Fan, Y., Niu, X., et al. (2015). HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene 34, 5617-5625. doi: 10.1038/onc.2015.32
48. Weiwer, M., Bittker, J. A., Lewis, T. A., Shimada, K., Yang, W. S., Macpherson, L., et al. (2012). Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg. Med. Chem. Lett. 22, 1822-1826. doi: 10.1016/j.bmcl.2011.09.047
49. Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., et al. (2016). Ferroptosis: process and function. Cell Death Differ. 23, 369-379. doi: 10.1038/cdd.2015.158
50. Yagoda, N., Von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., et al. (2007). RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864-868. doi: 10.1038/nature05859
51. Yamaguchi, H., Hsu, J. L., Chen, C. T., Wang, Y. N., Hsu, M. C., Chang, S. S., et al. (2013). Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cells. Clin. Cancer Res. 19, 845-854. doi: 10.1158/1078-0432.CCR-12-2621
52. Yang, W. S., Kim, K. J., Gaschler, M. M., Patel, M., Shchepinov, M. S., and Stockwell, B. R. (2016). Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. U.S.A. 113, E4966-E4975. doi: 10.1073/pnas.1603244113
53. Yang, W. S., Shimada, K., Delva, D., Patel, M., Ode, E., Skouta, R., et al. (2012). Identification of simple compounds with microtubule-binding activity that inhibit cancer cell growth with high potency. ACS Med. Chem. Lett. 3, 35-38. doi: 10.1021/ml200195s
54. Yang, W. S., Sriramaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., et al. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317-331. doi: 10.1016/j.cell.2013.12.010
55. Yang, W. S., and Stockwell, B. R. (2008). Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234-245. doi: 10.1016/j.chembiol.2008.02.010
56. Yant, L. J., Ran, Q., Rao, L., Van Remmen, H., Shibatani, T., Belter, J. G., et al. (2003). The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic. Biol. Med. 34, 496-502. doi: 10.1016/S0891-5849(02)01360-6
57. Yu, Y., Xie, Y., Cao, L., Yang, L., Yang, M., Lotze, M. T., et al. (2015). The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol. Cell. Oncol. 2:e1054549. doi: 10.1080/23723556.2015.1054549